Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVianet Grp Regulatory News (VNET)

Share Price Information for Vianet Grp (VNET)

Share Price is delayed by 15 minutes
Get Live Data
69.50    0.50 (0.72%)
Bid:
67.00
Ask:
72.00
Spread: 5.00 (7.463%)
Market Cap: £19.76m
VNET Live PriceLast checked at - London Stock Exchange

Intraday Vianet Grp Share Chart

Rule 8.3- Brulines Group Plc

2 Nov 2009 10:48

RNS Number : 7618B
Williams de Bro? Limited
02 November 2009
 



FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE 

(Rule 8.3 of the Takeover Code)

1. KEY INFORMATION

Name of person dealing  (Note 1)

WILLIAMS DE BROË LIMITED

Company dealt in

BRULINES GROUP PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORD

Date of dealing

30/10/2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

509,718  1.826%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

509,718  1.826%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

Class of relevant security:

Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 5)

PURCHASE

6,000

1.39 GBP

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 5) 

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

2 NOVEMBER 2009

Contact name

CAROLINE DANIELS

Telephone number

020 7847 8189

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUUGPWGUPBGUP
Date   Source Headline
3rd Dec 202412:02 pmRNSShare Buyback Prorgramme
3rd Dec 20247:00 amRNSInterim Results
4th Nov 20244:10 pmRNSHolding(s) in Company
4th Nov 20249:05 amRNSInvestor Presentation via Investor Meet Company.
4th Nov 20247:00 amRNSTrading Update and Notice of Results
5th Sep 202411:30 amRNSExercise of Options
18th Jul 202412:45 pmRNSResult of AGM
18th Jul 20247:00 amRNSAGM Statement
20th Jun 202412:00 pmRNSAnnual Financial Report
11th Jun 20247:00 amRNSFinal Results
29th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
25th Apr 20247:01 amRNSTrading Update and Notice of Results
25th Apr 20247:00 amRNSContract Win
4th Apr 202410:30 amRNSExercise of options
14th Mar 20242:00 pmRNSExercise of Options
24th Jan 20244:38 pmRNSDirector/PDMR Shareholding
23rd Jan 20244:15 pmRNSDirector/PDMR Shareholding
18th Jan 20246:20 pmRNSShare Buyback and Total Voting Rights
10th Jan 20246:15 pmRNSShare Buyback and Total Voting Rights
9th Jan 20247:00 amRNSShare Buyback and Total Voting Rights
8th Jan 20247:00 amRNSShare Buyback and Total Voting Rights
2nd Jan 20247:00 amRNSShare Buyback and Total Voting Rights
22nd Dec 202312:45 pmRNSShare Buyback and Total Voting Rights
18th Dec 202310:00 amRNSShare Buyback and Total Voting Rights
15th Dec 202312:00 pmRNSHolding(s) in Company
14th Dec 20239:15 amRNSShare Buyback and Total Voting Rights
12th Dec 20237:00 amRNSHalf-year Report
4th Dec 20239:30 amRNSInvestor Presentation via Investor Meet Company
13th Nov 20237:00 amRNSDirector/PDMR Shareholding
9th Nov 20231:10 pmRNSFurther re Share Buyback
7th Nov 20232:28 pmRNSShare Buyback Prorgramme
6th Nov 202310:17 amRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSTrading Update and Notice of Results
9th Oct 20232:48 pmRNSChange of Adviser
13th Sep 202311:46 amRNSAnnual Financial Report
5th Sep 202312:20 pmRNSResult of AGM
5th Sep 20237:00 amRNSAGM Statement
14th Jun 20231:47 pmRNSExercise of Options
13th Jun 202311:12 amRNSReplacement RNS: Final Results
13th Jun 20237:00 amRNSFinal Results
5th Jun 20231:49 pmRNSNotice of Results and Investor Presentation
5th Jun 20237:00 amRNSHMRC R&D Tax Refund
15th May 20237:00 amRNSStrategic acquisition of trade and assets
2nd May 20237:00 amRNSTrading Update and Notice of Results
21st Mar 20237:00 amRNSVianet partners with Vendekin Technologies
20th Feb 20232:38 pmRNSGrant of Options
1st Feb 202312:00 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSHalf-year Report
25th Nov 20227:00 amRNSUnattended contactless payment solution launched
18th Nov 20227:00 amRNSInvestors Meet Company : Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.